Stockreport

Bayer's (BAYRY) AskBio Advances Parkinson Disease Study [Yahoo! Finance]

BAYER AG S/ADR  (BAYRY) 
NASDAQ:AMEX Investor Relations: investor.bayer.com
PDF REGENERATE-PD is a phase II study evaluating the efficacy and safety of AB-1005, an investigational adeno-associated virus 2 (AAV2) glial cell line-derived neurotrophic [Read more]